A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

NCT07070232 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

980

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: BNT326
DRUG: Pumitamig
DRUG: Itraconazole
DRUG: Paroxetine

Sponsor

BioNTech SE

Collaborators

[object Object]